1/47
Looks like no tags are added yet.
What are the Main Causes of Abnormal Bleeding?
Trauma
Thrombocytopenia
Platelet dysfunction
Vasculopathy
Coagulation factor disorders.
What are the Key Pre-Analytical Requirements for Coagulation Testing?
Use citrated blood (blue-top tube) with a 9:1 blood-to-citrate ratio
Perform clean venipuncture
Avoid platelet activation or tissue factor contamination
Why is Sodium Citrate Used for Coagulation Testing?
It reversibly binds calcium to prevent clotting
Calcium is added back during laboratory testing
How Should Plasma Samples Be Processed for Coagulation Testing?
Separate plasma within 1 hour
Test within 4 hours when possible, and freeze separated plasma if delayed
Follow laboratory-specific instructions
Which Tests Evaluate Primary Hemostasis?
CBC/platelet count
Buccal mucosal bleeding time (BMBT)
Aggregometry
PFA-100
von Willebrand factor testing
Genetic testing,
Specialized platelet function assays
What are the Limitations of Buccal Mucosal Bleeding Time (BMBT)?
It is easy to perform but variable and relatively insensitive
Results are affected by platelet number and function.
What is the General Principle of Clotting-Time Assays?
Add coagulation activators, calcium, and phospholipids as needed, then measure the time until clot formation using visual, mechanical, or optical detection
What is Activated Clotting Time (ACT), and How is It Performed?
A whole-blood test using an intrinsic-pathway activator tube incubated at 37°C
Clot formation is detected visually
What are the Normal ACT Reference Intervals for Dogs and Cats?
Dogs: 55–80 seconds
Cats: 55–85 second
Reference intervals depend on the method.
What Does a Prolonged ACT Indicate?
Severe intrinsic or common pathway factor deficiencies or severe thrombocytopenia
ACT is relatively insensitive

What is Activated Partial Thromboplastin Time (aPTT), and How is It Performed?
A citrated plasma test using an intrinsic-pathway activator, phospholipids, and calcium to measure clotting time
What Does a Prolonged aPTT Indicate?
Deficiency or dysfunction of intrinsic or common pathway factors
It is more sensitive than ACT and is not prolonged by thrombocytopenia alone
What is Prothrombin Time (PT), and How is It Performed?
A citrated plasma test using tissue factor, phospholipids, and calcium to activate the extrinsic pathway and measure clotting time
What Does a Prolonged PT Indicate?
Deficiency or dysfunction of extrinsic or common pathway factors
It is not prolonged by thrombocytopenia alone
How Do ACT, aPTT, and PT Differ?
ACT:
Intrinsic/common pathways
Whole blood
Relatively insensitive
Affected by severe thrombocytopenia
aPTT:
Intrinsic/common pathways
Citrated plasma
More sensitive
Unaffected by thrombocytopenia
PT:
Extrinsic/common pathways
Citrated plasma
Unaffected by thrombocytopenia.
How are PT and aPTT Results Interpreted Together?
Prolonged aPTT only → intrinsic pathway abnormality
Prolonged PT only → extrinsic pathway abnormality
Both prolonged → common pathway or multiple factor abnormalities
What is INR, and What is Its Purpose?
International normalized ratio
A unitless ratio used to standardize PT results across laboratories
What is PIVKA, and What Does the Veterinary PIVKA Test Evaluate?
Proteins induced by vitamin K antagonism or absence
Veterinary testing uses a modified PT-based assay to assess reduced activity of factors II, VII, and X
It does not directly measure PIVKA proteins
Which Coagulation Factors Require Vitamin K?
Factors II, VII, IX, and X
Vitamin K is required for their functional γ-carboxylation
What is Thrombin Time (TT/TCT), and What Does It Evaluate?
Thrombin is added to citrated plasma to measure fibrinogen conversion into fibrin
Abnormalities include dysfibrinogenemia and fibrin polymerization inhibitors
What is the Clauss Method for Measuring Fibrinogen?
A modified thrombin time assay that measures functional fibrinogen concentration
Preferred over heat precipitation
What is the Russell Viper Venom Test (RVVT)?
A citrated plasma assay using Russell's viper venom to activate factors X and V
Sensitive to antiphospholipid antibodies and rarely used in veterinary medicine
What is Viscoelastic Testing, and Which Methods are Used?
A global assessment of clot initiation, formation, strength, and breakdown over time
Methods include TEG, ROTEM, and Sonoclot.
What is the Main Advantage and Limitation of Viscoelastic Testing?
It evaluates multiple stages of clot development and fibrinolysis, but the test system lacks endothelial cells.
What Do the Main TEG/ROTEM Parameters Measure?
R/CT: time to clot initiation
K/CFT and α-angle: rate of clot formation
MA/MCF: maximum clot strength
LY30/LY60: clot breakdown
What Viscoelastic Findings Suggest Hypercoagulability vs. Hypocoagulability?
Hypercoagulability: shorter R/CT and K/CFT, increased α-angle and clot strength
Hypocoagulability: prolonged R/CT and K/CFT, decreased α-angle and clot strength

How is Increased Fibrinolysis Identified with Viscoelastic Testing?
Increased clot breakdown on the tracing and increased lysis measurements
Adding tPA can improve detection of fibrinolysis.
How are Specific Coagulation Factor Activities Measured?
Specialized laboratories use modified PT/aPTT assays with factor-deficient plasma or chromogenic assays
Results are reported as percentage activity
What is the Main Mechanism of Fibrinolysis?
tPA converts plasminogen into plasmin → which degrades fibrin and fibrinogen into degradation products

How is Fibrinolysis Regulated?
PAIs inhibit plasminogen activation
α2-antiplasmin and α2-macroglobulin inhibit free plasmin
TAFI limits fibrinolysis

What are Fibrin/Fibrinogen Degradation Products (FDPs)?
Products of fibrinogen and fibrin breakdown, measured by immunoassays
Elevations may reflect increased fibrinolysis, fibrinogenolysis, or decreased clearance
What are D-Dimers, and What Do They Indicate?
Products specifically generated from degradation of cross-linked fibrin → indicating fibrin formation followed by breakdown
How Do FDPs and D-Dimers Differ?
FDPs: indicate degradation of fibrinogen or fibrin
Not specific for cross-linked fibrin
D-dimers: specifically indicate degradation of cross-linked fibrin

How is Antithrombin (AT) Activity Measured?
A functional chromogenic assay measures inhibition of added thrombin or factor Xa
Greater AT activity produces less color
What are the Main Causes of Decreased Antithrombin Activity?
Decreased production
Increased loss
Consumption during excessive coagulation
How is Protein C Activity Measured, and What Can Alter It?
A functional chromogenic assay reported as percentage activity
Changes may reflect impaired production, vitamin K antagonism, or altered activation
QUESTION: A 5 month old MI Yorkshire Terrier, presented to your clinics with a presenting complaint of lameness and subcutaneous hematoma. You ran a coagulation panel which indicated normal platelet count, PTT-24 sec (RI 8.5-15.5) sec, PT-12.3 sec (RI 11-15.5), TCT 6 sec (RI 5-9).
Which of the following coagulation factors is most likely to be deficient?
A. Factor 5 (V)
B. Factor 7 (VII)
C. Factor 8 (VIII)
D. Factor 1 (fibrinogen)
ANSWER → C. Factor VIII
Prolonged PTT indicates an intrinsic or common pathway abnormality.
Normal PT makes a common pathway deficiency less likely.
Normal TCT suggests that the final fibrinogen-to-fibrin step is functioning.
Factor VIII belongs to the intrinsic pathway.
Key takeaway: Isolated prolonged PTT → suspect an intrinsic pathway factor deficiency (VIII, IX, XI, or XII).
QUESTION: What is the most likely etiology of Skip’s coagulopathy?
A. Factor 8 deficiency (Hemophilia A)
B. Factor 9 deficiency (Hemophilia B)
C. Immune mediated thrombocytopenia
D. Vitamin K antagonism (rodenticide toxicity)
ANSWER → D. Vitamin K antagonism (rodenticide toxicity)
The professor explicitly explains that Skip's severe anemia and hypoproteinemia suggest acute hemorrhage. Both PT and PTT are markedly prolonged, indicating abnormalities affecting multiple coagulation pathways.
Vitamin K antagonism impairs the activity of factors II, VII, IX, and X.
Key takeaway: Prolonged PT + prolonged PTT, with severe hemorrhage, should raise suspicion for vitamin K antagonism.
QUESTION: 7 year old MC Lab presented for lethargy, increased respiratory rate and effort. Lab work shows thrombocytopenia (22K), prolonged PT (>120 sec) and PTT (>140 sec), decreased fibrinogen (<50 mg/dl), decreased AT activity (30%) and increased D-dimer (1056 ng/ml). Liver values on serum biochemistry are unremarkable.
A. Consumption
B. Vitamin K antagonism
C. Decreased production
D. Loss via intestinal hemorrhage
ANSWER → A. Consumption
Widespread coagulation activation consumes platelets, factors, fibrinogen, and antithrombin while generating cross-linked fibrin that undergoes breakdown.
Meanwhile, increased D-dimers indicate that cross-linked fibrin is being formed and broken down.
Key takeaway: Thrombocytopenia + prolonged PT/PTT + decreased fibrinogen + decreased antithrombin + increased D-dimers suggests a consumptive coagulopathy.
What is the Recommended Initial Hemostasis Testing Panel, and What is Its Main Limitation?
Platelet count, PT, aPTT, fibrinogen concentration, and D-dimers
Hypercoagulability is generally harder to detect than hypocoagulability.
TABLE 1. Hemostasis Tests: What Does Each Test Evaluate?
Test | Evaluates | Main Purpose |
Platelet count | Primary hemostasis | Detect thrombocytopenia |
BMBT | Primary hemostasis | Assess platelet plug formation |
ACT | Intrinsic + common pathways | Screen for severe coagulation abnormalities |
aPTT | Intrinsic + common pathways | Detect intrinsic/common factor abnormalities |
PT | Extrinsic + common pathways | Detect extrinsic/common factor abnormalities |
TT/TCT | Fibrinogen → fibrin | Evaluate fibrin formation |
Clauss fibrinogen | Functional fibrinogen | Measure fibrinogen concentration |
TEG/ROTEM | Global hemostasis | Assess clot formation, strength, and breakdown |
FDPs | Fibrin/fibrinogen breakdown | Detect increased degradation products |
D-dimer | Cross-linked fibrin breakdown | Detect fibrin formation followed by degradation |
AT activity | Natural anticoagulation | Assess antithrombin function |
Protein C activity | Natural anticoagulation | Assess protein C function |
Key concept: Different assays evaluate different parts of hemostasis. No single test identifies every bleeding or thrombotic disorder.
TABLE 2. ACT vs. aPTT vs. PT
Feature | ACT | aPTT | PT |
Sample | Whole blood | Citrated plasma | Citrated plasma |
Pathway | Intrinsic + common | Intrinsic + common | Extrinsic + common |
Activator | Contact activator | Contact activator | Tissue factor |
Calcium added? | No, typically | Yes | Yes |
Sensitivity | Relatively low | Higher than ACT | Sensitive to extrinsic pathway abnormalities |
Severe thrombocytopenia affects result? | Yes | No | No |
Main use | Rapid screening | Factor abnormalities | Factor abnormalities |
Memory trick:
aPTT = Inside (intrinsic pathway).
PT = Tissue factor (extrinsic pathway).
ACT = A Crude Test (less sensitive than aPTT).
TABLE 3. Interpreting PT and aPTT Together
PT | aPTT | Interpretation | Possible Factor Abnormalities |
Normal | Normal | No detectable abnormality in these assays | Mild deficiencies and platelet disorders still possible |
Normal | Prolonged | Intrinsic pathway | VIII, IX, XI, XII |
Prolonged | Normal | Extrinsic pathway | VII |
Prolonged | Prolonged | Common pathway or multiple factors | X, V, II, I or multiple deficiencies |
Important: A prolonged clotting time means the sample takes longer to form a clot. It does not automatically tell you which specific factor is deficient.
TABLE 4. Fibrinolysis Testing: FDPs vs. D-Dimers
Feature | FDPs | D-Dimers |
What is detected? | Fibrinogen and fibrin degradation products | Cross-linked fibrin degradation products |
Sample | Usually citrated plasma | Citrated plasma |
Method | Immunoassay, commonly latex agglutination | Immunoassay, commonly latex agglutination |
Reported units | µg/mL | ng/mL |
Increased results suggest | Increased fibrinolysis, fibrinogenolysis, or decreased clearance | Increased cross-linked fibrin breakdown or decreased clearance |
Specific for cross-linked fibrin? | No | Yes |
Memory trick:
FDP = Fibrin OR fibrinogen degradation.
D-dimer = Degradation of cross-linked fibrin.
D-dimers therefore provide more specific evidence that a stabilized fibrin clot was formed and subsequently broken down.
TABLE 5. Viscoelastic Testing (TEG vs. ROTEM)
Parameter | TEG | ROTEM | Hypercoagulable | Hypocoagulable |
Clot initiation | R | CT | Shortened | Prolonged |
Clot formation rate | K, α-angle | CFT, α-angle | Shorter K/CFT, higher α | Longer K/CFT, lower α |
Clot strength | MA, G | MCF | Increased | Decreased |
Clot breakdown | LY30/LY60 | CLI30/CLI60 | Assesses fibrinolysis separately | Assesses fibrinolysis separately |
Key concept:
Unlike PT and aPTT, which measure time until clot formation
TEG/ROTEM assess the clot's development, strength, and breakdown over time
TABLE 6. Specialized Assays and Endogenous Anticoagulants
Assay | Method | What It Evaluates |
PIVKA | Modified PT-based assay | Reduced activity of vitamin K-dependent factors II, VII, X |
TT/TCT | Add thrombin to citrated plasma | Fibrinogen conversion to fibrin |
Clauss fibrinogen | Modified thrombin time | Functional fibrinogen concentration |
RVVT | Russell's viper venom activates factors X and V | Coagulation activity; sensitive to antiphospholipid antibodies |
Specific factor activity | Modified PT/aPTT or chromogenic assays | Activity of an individual coagulation factor |
Antithrombin activity | Functional chromogenic assay | Inhibition of thrombin or factor Xa |
Protein C activity | Functional chromogenic assay | Protein C anticoagulant activity |
Causes of Decreased Anticoagulant Activity
Anticoagulant | Possible Causes of Decreased Activity |
Antithrombin | Decreased production, increased loss, consumption |
Protein C | Decreased production, vitamin K antagonism, altered activation |
Important: In the antithrombin chromogenic assay, greater AT activity means more inhibition of the added protease and therefore less color production
TABLE 7. Clinical Interpretation of Hemostasis Results
Clinical Findings | Interpretation | Example |
Prolonged aPTT, normal PT and TCT | Intrinsic factor deficiency | Factor VIII deficiency (hemophilia A) |
Prolonged PT, normal aPTT | Extrinsic factor abnormality | Factor VII deficiency |
Prolonged PT and aPTT with severe hemorrhage | Multiple coagulation factor deficiencies | Vitamin K antagonism |
Thrombocytopenia + prolonged PT/aPTT + low fibrinogen + low AT + high D-dimers | Consumptive coagulopathy | Widespread coagulation activation |
Increased D-dimers | Cross-linked fibrin formation and breakdown | Increased fibrin turnover |
Short R/CT + high MA/MCF | Hypercoagulable viscoelastic pattern | Increased clot strength |
Important distinction: These patterns suggest particular mechanisms, but diagnosis requires the patient's history, examination, and additional laboratory findings.